期刊
MULTIPLE SCLEROSIS AND RELATED DISORDERS
卷 56, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2021.103287
关键词
Multiple sclerosis; Ocrelizumab; CD19; Extended dosing